Research collaboration develops new engineered T-cell therapy for type 1 diabetes (IMAGE)

Seattle Children's

Research collaboration develops new engineered T-cell therapy for type 1 diabetes

Caption

Dr. Jane Buckner of the Benaroya Research Institute at Virginia Mason and Dr. David Rawlings at Seattle Children's Research Institute are leading research to develop an engineered T-cell therapy for type 1 diabetes.

Credit

Seattle Children's

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.